HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

benzanthrone

RN given refers to parent cpd

Also Known As:

benzanthrone, dilithium salt (-2); 7H-benz(de)anthracen-7-one

Networked: 13 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Benz(a)Anthracenes: 2
        benzanthrone: 13
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Benz(a)Anthracenes: 2
    - benzanthrone: 13

Experts

1.	Abbas, Sabiya: 2 articles (01/2017 - 10/2016)
2.	Alam, Shamshad: 2 articles (01/2017 - 10/2016)
3.	Ansari, Kausar M: 2 articles (01/2017 - 09/2013)
4.	Kumar, Mahadeo: 2 articles (01/2017 - 10/2016)
5.	Khanna, S K: 2 articles (09/2013 - 06/2001)
6.	Kalnina, Inta: 2 articles (12/2009 - 11/2007)
7.	Kirilova, Elena: 2 articles (12/2009 - 11/2007)
8.	Klimkane, Laura: 2 articles (12/2009 - 11/2007)
9.	Gupta, Shailendra K: 1 article (01/2017)
10.	Singh, Krishna P: 1 article (01/2017)

Related Diseases

1.	Photosensitivity Disorders (Photodermatitis) 08/01/1985 - "The action spectrum for benzanthrone photosensitization of mouse macrophages." 09/01/1990 - "In skin-photosensitization studies on guinea-pigs benzanthrone induced significant erythema and oedema, depending upon the doses both of benzanthrone and of sunlight or artificially simulated UVA radiation. "
2.	Inflammation (Inflammations) 10/01/2016 - "This study was conducted to explore the role of UVB on benzanthrone (BA)-induced skin inflammation and its mechanism/s. "
3.	Erythema 09/01/1990 - "In skin-photosensitization studies on guinea-pigs benzanthrone induced significant erythema and oedema, depending upon the doses both of benzanthrone and of sunlight or artificially simulated UVA radiation. "
4.	Neoplasms (Cancer) 09/01/2013 - "Thus, attempts were made to elucidate the tumor initiating and promoting potentials of pure (PBA) and commercial benzanthrone (CBA). " 11/01/2007 - "The fluorescent probe-aminoderivative of benzanthrone, ABM (developed at Riga Technical University, Riga, Latvia) was used to characterize the membranes of lymphocytes of cancer patients: 46 patients with gastrointestinal diseases, 13 patients having different primary localizations with massive metastases and intoxication. " 12/01/2009 - "The fluorescent probe ABM (an amino derivative of benzanthrone) developed at Riga Technical University (Riga, Latvia) was used to characterize the blood plasma albumin of cancer patients (46 gastrointestinal cancer patients--30 with colorectal cancer in Stages II-IV and 16 with gastric cancer in Stage III) and of healthy controls. "
5.	Body Weight (Weight, Body) 01/01/1991 - "Parenteral administration of benzanthrone (40 mg/kg body weight) for 3, 7, or 21 days caused no change in the relative body weight or organ weight of rats. " 06/01/2001 - "Oral administration of benzanthrone (50, 125 or 250 mg/kg body weight) resulted in a significant increase of urinary AsA levels with a concomitant decrease in the urinary dehydroascorbic acid (DHA) content in both rats and guinea-pigs. "

Related Drugs and Biologics

1.	Metyrapone
2.	Fluorescent Dyes (Fluorescent Probes)
3.	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
4.	Coloring Agents (Dyes)
5.	Dehydroascorbic Acid
6.	Carbon Monoxide
7.	Albumins
8.	loxoribine
9.	phenylamil

Related Therapies and Procedures

1.	Oral Administration